Skip to playerSkip to main content
  • 5 years ago
The Subject Expert Committee (SEC) has recommended Phase 1 clinical trials of Reliance Life Sciences' two-dose Covid-19 vaccine candidate. Now, approval by the Drugs Controller General of India (DCGI) is required, following which Reliance Life Sciences can commence Phase 1 trials of the Covid-19 vaccine.

Category

🗞
News

Recommended